Maharashtra FDA Cancels Cipla's Pune Distribution Licenses
Maharashtra's Food and Drug Administration has cancelled Cipla Pharma's distribution licenses in Pune due to serious violations. Inspections revealed irregularities with Reactin Plus Tablets, including misbranding and unsafe storage. Expired medicines were stored improperly without proper documentation. The FDA's decision followed earlier proceedings and legal directions addressing these violations.
Economic Times··Pune



